Uncategorized
Allotex, Inc. Announces Financing for Presbyopia Clinical Trials
BOSTON--(BUSINESS WIRE)--Allotex, a private company developing the TransForm Corneal Allograft (TCA) for the treatment of presbyopia, has closed on financing from, a strategic investor, to fund its upcoming European clinical trials. The company was founded in 2016 by Dr. David Muller and Professor Michael Mrochen has a research facility in Zurich, Switzerland with production and corporate offices in Boston, MA. The TCA is created using natural human corneal tissue which has been shaped using hi